Ardelyx | ARDX - Current Assets


Ardelyx reported $367.98M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
Ardelyx USD 367.98M 16.42M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Curis USD 14.42M 10.39M Jun/2025
Sanofi EUR 30.95B 8.99B Dec/2025
TG Therapeutics USD 599.76M 64.2M Sep/2025
United Therapeutics USD 3.49B 332.9M Sep/2025
Xoma USD 110.71M 5.78M Sep/2025